BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29886551)

  • 1. Detecting Circulating MicroRNAs as Biomarkers in Alzheimer's Disease.
    Kenny A; Jimenez-Mateos EM; Calero M; Medina M; Engel T
    Methods Mol Biol; 2018; 1779():471-484. PubMed ID: 29886551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid.
    Denk J; Jahn H
    Methods Mol Biol; 2018; 1750():93-107. PubMed ID: 29512067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MicroRNA Next-Generation-Sequencing Discovery Assay (miND) for Genome-Scale Analysis and Absolute Quantitation of Circulating MicroRNA Biomarkers.
    Khamina K; Diendorfer AB; Skalicky S; Weigl M; Pultar M; Krammer TL; Fournier CA; Schofield AL; Otto C; Smith AT; Buchtele N; Schoergenhofer C; Jilma B; Frank BJH; Hofstaetter JG; Grillari R; Grillari J; Ruprecht K; Goldring CE; Rehrauer H; Glaab WE; Hackl M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs as novel biomarkers of Alzheimer's disease.
    Zendjabil M
    Clin Chim Acta; 2018 Sep; 484():99-104. PubMed ID: 29800558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer's Disease Biomarker Discovery.
    Takousis P
    Methods Mol Biol; 2018; 1750():283-292. PubMed ID: 29512080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
    Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
    J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of microRNA‑222 in serum of patients with Alzheimer's disease.
    Zeng Q; Zou L; Qian L; Zhou F; Nie H; Yu S; Jiang J; Zhuang A; Wang C; Zhang H
    Mol Med Rep; 2017 Oct; 16(4):5575-5579. PubMed ID: 28849039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying miRNA Deregulation in Alzheimer's Disease.
    Cardoso AL; Guedes JR
    Methods Mol Biol; 2018; 1750():307-319. PubMed ID: 29512082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems Biology Approaches to the Study of Biological Networks Underlying Alzheimer's Disease: Role of miRNAs.
    Roth W; Hecker D; Fava E
    Methods Mol Biol; 2016; 1303():349-77. PubMed ID: 26235078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
    Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
    Hong H; Li Y; Su B
    J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
    de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
    J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Biomarker Panels in Alzheimer's Disease.
    Zafari S; Backes C; Meese E; Keller A
    Gerontology; 2015; 61(6):497-503. PubMed ID: 25720553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
    Dong A; Toledo JB; Honnorat N; Doshi J; Varol E; Sotiras A; Wolk D; Trojanowski JQ; Davatzikos C;
    Brain; 2017 Mar; 140(3):735-747. PubMed ID: 28003242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput RT-qPCR for the Analysis of Circulating MicroRNAs.
    Tan GW; Tan LP
    Methods Mol Biol; 2017; 1580():7-19. PubMed ID: 28439823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease.
    Lillenes MS; Rabano A; Støen M; Riaz T; Misaghian D; Møllersen L; Esbensen Y; Günther CC; Selnes P; Stenset VT; Fladby T; Tønjum T
    Mol Brain; 2016 May; 9(1):61. PubMed ID: 27234294
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.